Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer
Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership.
April 8, 2026
EXECUTIVE APPOINTMENTS
Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer
Brown brings more than 20 years of experience in mitochondrial research and scientific team leadership.